Resources

The latest in formulation & delivery research, from discovery and multi-omics approaches through to diagnostics development

Drug Formulation

The Roadmap of ADC Formulation & Delivery: Achievements and Obstacles

Dive into the progress and challenges in Antibody-Drug Conjugates formulation and delivery for cancer treatment. We emphasize the advancements in targeting precision and efficacy, while discussing key development challenges like target selection, drug potency, and manufacturing complexities in this evolving oncology field.
Drug Formulation

Kurma Partners to Collaborate with Samsung Biologics for the Development and Manufacture of Biologics Drugs

Samsung Biologics will develop and manufacture drugs for Kurma’s portfolio companies, including by providing CMC drug development.
Drug Formulation

Interviewing Rishabh Tukra, Process Development Senior Scientist at Amgen

Before joining Amgen, Dr Tukra got his PhD from Purdue University in Industrial and Physical Pharmacy. While at Purdue he also worked at LyoHUB as an advisor and researcher in industrial and academic projects.
Drug Formulation

Achieving Faster Formulation of Solid Oral Dosage Forms for First-in-human Supplies Using Drug-in-capsule Approach

The pharmaceutical industry is increasingly looking for approaches to shorten drug development timelines and save on cost, especially virtual biotech companies who rely heavily on key milestone payments. It is therefore imperative that new chemical entities can be quickly manufactured quickly into clinical drug products.
Drug Formulation

Almac Pharma Services

Tailor-made pharmaceutical development & commercial solutions.
Drug Formulation

Almac: Paediatric Drug Product Development Through to Commercialisation

How Almac developed a flexible paediatric dosage form using a robust manufacturing and filling process suitable for routine commercial manufacture.
Drug Formulation

Almac: Pharmaceutical Development

Specialising in solid oral dose formulations, 300,000ft² of drug product development footprint, multiple containment strategies for highly potent materials.
Drug Formulation

Aptar Pharma: Reliable Development, Reliable Effect

Aptar Pharma’s range of UDS (Unidose system) systems, particularly the UDS powder, is a proven, ready-to-use platform, providing a precise single dose via the nose quickly and easily.
Drug Formulation

Cell and Gene Therapies Analytical Development Services

CMC development support, characterisation, stability and quality control services.
Drug Formulation

Inhaled & Intranasal Biologic Drug Development

Contract drug development expertise to accelerate your inhaled biomolecule to market.
Drug Formulation

Intertek Biopharmaceutical Services

To meet your development milestones and comply with regulatory requirements, you will need high quality bioanalytical and analytical data to aid informed decision-making and identify sources of risk.
Drug Formulation

Intertek: GMP & CMC Laboratory Services

Stability programs are a fundamental component of pharmaceutical product development, playing an essential role across the lifecycle of pharmaceutical products.
Drug Formulation

Intertek: Support for Small & Large Molecules Across All Respiratory Delivery Technology Platforms

30+ years of experience inhaled and nasal product development.
Drug Formulation

mRNA Vaccine and Therapeutic Products Analytical Development Services

CMC development support, characterisation, stability, and quality control services.
Drug Formulation

Orally Inhaled and Nasal Drug Product (OINDP) Development and Testing

Support for Metered Dose Inhalers, Dry Powder Inhalers (DPIs), Nasal sprays and other classes of OINDP.
Drug Formulation

Pharmaceutical Bioanalysis Services

Bioanalytical Expertise from Preclinical to Commercialisation
Drug Formulation

Pharmaceutical Services Laboratory & Assurance Solutions

Across your product lifecycle, our expertise brings you the insight you need to accelerate pharmaceutical, biopharmaceutical or medical device product development.
Drug Formulation

The Experic Difference for Analytical Services

Experic’s analytical services provide powerful support at every phase of pharmaceutical development and manufacturing.
Drug Formulation

The Experic Difference for Customized Particle Engineering

Solve Development Scale Powder Challenges with Spray Drying Technology. Control Particle Size and Morphology and Enhance Solubility and Bioavailability with Spray Dried Dispersions.
Drug Formulation

The Experic Difference for Dry Powder Inhalation

When you need customized and scalable filling, packaging and logistics solutions for reservoir and single-dose dry powder inhalation (DPI) devices, Experic offers an experienced team and state-of-the-art capabilities.
Drug Formulation

Toward Sustainable Packaging Solutions for Drug Manufacturers

In the quest for sustainable packaging solutions in the pharmaceutical industry, drug manufacturers are grappling with the need to reduce waste while maintaining the stringent requirements for medicine packaging.
Drug Formulation

Sustainable Drug Formulation: Paving the Path for Greener Pharmaceutical Future

What are the top eco-friendly drug formulation techniques in green pharma? Explore the intersection of pharmaceuticals and sustainability. Dive into sustainable drug formulation, understand its environmental implications, and discover how the industry is innovating for a greener future.
Drug Formulation

What is Spray Freeze Drying?

Unlocking the potential of spray freeze drying: Challenges and strategies for commercialization
Drug Formulation

New Freeze-Drying Technologies: Pfizer's Quest for Sustainable Cooling

Pfizer continues to explore even greener alternatives to traditional lyophilisation methods like air cooling in its pursuit of environmental sustainability.
Drug Formulation

Vanguard Strategies: Perspectives on Developing Novel Pharma Technologies

Novel technologies in drug development, including personalized medicine manufacturing, cyclic peptides, and continuous manufacturing methods.
Drug Formulation

TC1 Bacterium Identified by GSK Could be Key to Controlling the Spread of Malaria

Researchers from GSK and John Hopkins University have discovered a strain of bacteria which can lower the amount of malaria carried by mosquitoes.
Drug Formulation

New HIV Drug Formulation Breakthrough for Paediatric Applications

While anti-retroviral therapies (ARTs) have transformed HIV from a death sentence into a manageable condition, paediatric applications of these therapies have remained limited.
Drug Formulation

Navigating the Drug Development Pipeline from Discovery to Product

If developers maintain a holistic plan for the entirety of the developmental process it increases the likelihood of a drug’s successful discovery.
Drug Formulation

The Discovery of Pancreatic Diabetes and Insulin Development

The discovery and isolation of insulin in 1921 revolutionised the treatment of diabetes, which previously had no real preventative approach. Researchers found that the pancreas plays a crucial role in regulating blood sugar levels, leading to the development of insulin.
Drug Formulation

The Untapped Potential of India’s Top CROs and CDMOs

Here, we look at the growing importance of India’s biotech companies, and the scope for collaboration with international pharmaceutical companies, with high-quality contract research organisations (CROs) capable of conducting diverse research projects.
Drug Formulation

Celanese Announces Collaboration with Alessa Therapeutics for the Advancement of Oncology Treatments

VitalDose® EVA drug delivery platform to be used in the development of Alessa Therapeutics’ proprietary localized drug delivery technology.
Drug Formulation

Advanced Formulation Development Strategies & Towards Sustainable Lyophilisation

Optimising drug delivery, stability, and patient outcomes through considerations such as formulation simplicity, critical temperatures, excipient selection, and the use of digital approaches.
Drug Formulation

BioDur-Sundia: Moving You Forward

End-to-End Solutions: Integrated Services to Navigate your BEST Path to Market
Drug Formulation

Development and Clinical Trial Material Manufacturing

BioDuro-Sundia’s Pharmaceutics team is well versed in turning challenging molecules to dosage forms ready for clinical trial in an efficient, reliable, and timely manner.
Drug Formulation

Solution Engine 2.0: Rapid Formulation Development of Amorphous Solid Dispersions by Combined In-Silico Modelling, High-Throughput Screening and in-vivo PK Study

Amorphous solid dispersion (ASD) technology has been successfully utilized to enhance solubility and bioavailability of poorly soluble APIs.
Drug Formulation

Globalizing Drug Development Programs for FDA Approval

Studies with a higher degree of representation will indicate patient populations that exhibit greater responsiveness to treatment, with global drug development programs integral to the safe development of future therapeutics.
Drug Formulation

Collaborative Drug Design Strategies for Broadening Approaches to Formulation and Delivery

Although the past three decades have seen significant increases in the cost and time associated with delivering new drugs for clinical use, efforts to increase the number of molecules arriving through the drug development pipeline have been underwhelming. But what if the solution has been hiding in plain sight?
Drug Formulation

Merck and XtalPi Collab for Computational Drug Development Techniques

The study highlighted the benefits of combining computational workflows with experimental validation for the rational engineering of desirable crystal habits, demonstrating how the collaboration is transforming pharmaceutical development and positively impacting patients' lives.
Drug Formulation

Blockbuster Drugs and Applications of AI in Accelerating the R&D Timeline for Drug Development

The future of AI in drug discovery and development looks promising. However, pharma’s big players need to ensure they’re prepared to deploy AI-capable workforces in the coming years.
Drug Formulation

FDA Publishes Paper Asking Manufacturers for Feedback on AI and Regulation

Key regulatory considerations for the application of AI to pharmaceutical manufacturing were outlined by the Center for Drug Evaluation and Research.
Drug Formulation

Three Ways AI and Machine Learning Will Enhance Drug Discovery and Drug Candidate Identification

Here, we explore three emerging technologies and the ways in which they’re helping to revolutionise the development of drugs, such as treatments for COVID-19, cancer research, and dementia.
Drug Formulation

“Stability Can be a Problem” — Dealing with Nanoparticle Stability Challenges in Drug Formulation

Cholesterol oxidation, working with regulators, drug loading nanoparticles, and functional excipients for specific pathways.
Drug Formulation

Long-Acting Injectables: Machine Learning in Drug Formulation and Therapeutic Development

Machine learning approaches may help to accelerate the formulation process for long-acting injectables, improving treatment options and therapeutic availability for patients.
Drug Formulation

How Can AI/ML Approaches Help Move Small Molecule Compounds Towards Regulatory Approval?

Incorporating AI/ML approaches into the holistic identification lifecycle can help to improve the efficiency of a compound reaching the next stage of validation, streamlining the initial identification process.
Drug Formulation

Cipla Stock Falls After 8 Observations from GMP Inspection

The Indian pharma giant comes out of inspection with eight observations in its generic manufacturing plant.
Drug Formulation

Celadon’s Medicinal Cannabis Facility Awarded GMP Registration by MHRA

The medicinal cannabis manufacturer Celadon Pharmaceuticals has had its facility in the Midlands registered as GMP by MHRA.
Drug Formulation

CROs, Strategy, and Sustainable Testing: Navigating Formulation Development for Biologics

An expert panel of formulation scientists discuss the challenges and solutions within the formulation development for biologics.
Drug Formulation

Leveraging In-Silico Tools for Optimised Process Development

Karsten Flügel of Merck Healthcare discusses how in-silico tools are used to optimise process development for drug production.
Drug Formulation

Experts Discuss the Particular Challenges of Biotherapeutic Formulation Development

Our Formulation discussion group this September focused on the unique challenges of developing formulations for biotherapeutics
Drug Formulation

Challenges in the Formulation of Biologics: Protein Aggregation, Safety, and Technology

Our panel discussion from Formulation UK 2021 highlights protein aggregation, safety, and novel technologies.
Drug Formulation

Analytical and Materials Science Solutions

Supporting pharmaceutical and consumer healthcare with development, validation, and application of testing methods.
Drug Formulation

Crystal16: The New Industry Standard

Crystal16 product sheet
Drug Formulation

Crystalline: Seeing is Believing

Access crystallization and formulation information at mL scale with the Crystalline series
Drug Formulation

Managing Complexity to Enhance Life

MUNIT is the world leading player in the field of particle size engineering for pharmaceutical substances, offering tailored solutions to enhance the physical behaviour of drug molecules.
Drug Formulation

Merck KGaA Application Services

Wide-ranging solutions. Unrivalled support
Drug Formulation

Merck KGaA: GMP Manufacturing Capabilities

Commercial Contract Manufacturing | Clinical Supply
Drug Formulation

Merck KGaA: Granulated Materials

Easy handling for improved process efficiency
Drug Formulation

Process Chemicals for RNA Drug Manufacturing

Providing high quality raw materials and services for mRNA manufacturing and formulation
Drug Formulation

Satisfy Your Regulatory Requirements

Transparency and comprehensive documentation with the Emprove® Program
Drug Formulation

tesa: By Your Side From Idea to Market

We Are Your Full Service CDMO for Transdermal Patches and Oral Films
Drug Formulation

Continuous Manufacturing: Challenges & Solutions

While new manufacturing technologies have the potentially to dramatically shift the way the pharmaceutical industry works, many challenges are preventing wider adoption.
Drug Formulation

API Particle Properties and the Importance of Crystallisation Technology

In this commentary article, we present Axel Becker's insights on the latest techniques governing API particle properties and the processes that dictate the success of drug reception and tablet compression.
Drug Formulation

A Look at New Process Development Techniques

How do we make the most of new techniques to optimise product development?
Drug Formulation

Accelerating Drug Development with Continuous Manufacturing

The pharmaceutical industry has historically taken a cautious approach to most new advancements, but now it is embracing the possibilities of continuous manufacturing technologies. While traditional batch-based processes are still more common, there are several products on the market that have utilized continuous manufacturing practices.

Subscribe to Our Newsletter

Sign up for our monthly newsletter to
keep up with all things formulation & delivery